Aytu BioScience Inc.
NASDAQ: AYTU
$7.82
+$0.15 (+2.0%)
Closing price March 1, 2021
Some small companies are destined to be small forever. Others can grow into huge companies over time. What will be the story for Aytu BioScience?
7 months ago
Aytu BioScience is a coronavirus play after moving into testing and treatment.
8 months ago
Last Updated: 8 months ago
Investors look at Aytu BioScience as it looks at expanding in the COVID testing field.
8 months ago
Last Updated: 8 months ago
Aytu BioScience has a distribution agreement for a COVID-19 rapid test and is developing a potential UV light-based treatment.
9 months ago
Last Updated: 9 months ago
This specialty pharmaceutical company is making good progress on multiple fronts, including changes to its board of directors and with its test for and treatment of COVID-19.
9 months ago
Aytu Bioscience has moved very quickly, both to execute agreements for products that can have an impact on the COVID-19 pandemic and to raise the capital it will take to provide a return on...
10 months ago
Aytu BioScience shares made an incredible gain to start the week following the firm’s announcement in regards to a coronavirus treatment.
10 months ago
Aytu BioScience has been one of the biggest winners in the fight against the novel coronavirus. The company is sending 2,700 COVID-19 rapid tests to Denver for use with first responders.
10 months ago
There is plenty of competition among companies wanting to sell coronavirus test kits. Aytu Biosciences has placed a bet on its ability to help beat the coronavirus outbreak.
11 months ago
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine, treatment or test to deal with this coronavirus and here is where their stocks stand now.
11 months ago
Aytu BioScience was largely unknown until it announced that it had a test for COVID-19. Since then, it has seen a meteoric rise in its common stock price. Does the future look bright?
11 months ago
Aytu Bioscience stock has had investors on a roller-coaster over the past week. The commercial-stage specialty pharmaceutical company has a COVID-19 test kit, but it's not the only one.
11 months ago
It is not a new scenario where an illness or problem starts to become a big deal in the public and there is a small-cap company that “has a solution for that” which happen to be known by...
11 months ago
More and more companies are joining the fight against the coronavirus, and 24/7 Wall St. is taking a look at some of the biggest movers on the day tied to COVID-19.
11 months ago